Similar articles for PMID: 20976136

Year	Number of Results
2006	2
2007	8
2008	2
2009	11
2010	9
2011	10
2012	5
2013	7
2014	9
2015	6
2016	2
2017	9
2018	7
2019	5
2020	3
2021	8
2022	4
2023	1
2024	1

1

Skin vaccination against cervical cancer associated human papillomavirus with a novel micro-projection array in a mouse model.

Corbett HJ, Fernando GJ, Chen X, Frazer IH, Kendall MA. Corbett HJ, et al. PLoS One. 2010 Oct 18;5(10):e13460. doi: 10.1371/journal.pone.0013460. PLoS One. 2010. PMID: 20976136 Free PMC article.

2

Expanded strain coverage for a highly successful public health tool: Prophylactic 9-valent human papillomavirus vaccine.

Zhang Z, Zhang J, Xia N, Zhao Q. Zhang Z, et al. Hum Vaccin Immunother. 2017 Oct 3;13(10):2280-2291. doi: 10.1080/21645515.2017.1346755. Hum Vaccin Immunother. 2017. PMID: 28699820 Free PMC article. Review.

3

Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males.

Bergman H, Buckley BS, Villanueva G, Petkovic J, Garritty C, Lutje V, Riveros-Balta AX, Low N, Henschke N. Bergman H, et al. Cochrane Database Syst Rev. 2019 Nov 22;2019(11):CD013479. doi: 10.1002/14651858.CD013479. Cochrane Database Syst Rev. 2019. PMID: 31755549 Free PMC article.

4

Cross-neutralizing antibody titres against non-vaccine types induced by a recombinant trivalent HPV vaccine (16/18/58) in rhesus macaques.

Wang Y, Liu Y, Liang S, Yin F, Zhang H, Liu Y. Wang Y, et al. Papillomavirus Res. 2020 Dec;10:100209. doi: 10.1016/j.pvr.2020.100209. Epub 2020 Nov 13. Papillomavirus Res. 2020. PMID: 33197649 Free PMC article.

5

Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Markowitz LE, et al. MMWR Recomm Rep. 2007 Mar 23;56(RR-2):1-24. MMWR Recomm Rep. 2007. PMID: 17380109 Free article.

6

Costs and cost-effectiveness of 9-valent human papillomavirus (HPV) vaccination in two East African countries.

Kiatpongsan S, Kim JJ. Kiatpongsan S, et al. PLoS One. 2014 Sep 8;9(9):e106836. doi: 10.1371/journal.pone.0106836. eCollection 2014. PLoS One. 2014. PMID: 25198104 Free PMC article.

7

Strategies for Developing Oral Vaccines for Human Papillomavirus (HPV) Induced Cancer using Nanoparticle mediated Delivery System.

Uddin MN, Kouzi SA, Hussain MD. Uddin MN, et al. J Pharm Pharm Sci. 2015;18(2):220-34. doi: 10.18433/j3rs3v. J Pharm Pharm Sci. 2015. PMID: 26158287 Free article. Review.

8

Comparison of the immunogenicity of Cervarix® and Gardasil® human papillomavirus vaccines for oncogenic non-vaccine serotypes HPV-31, HPV-33, and HPV-45 in HIV-infected adults.

Toft L, Tolstrup M, Müller M, Sehr P, Bonde J, Storgaard M, Østergaard L, Søgaard OS. Toft L, et al. Hum Vaccin Immunother. 2014;10(5):1147-54. doi: 10.4161/hv.27925. Epub 2014 Feb 19. Hum Vaccin Immunother. 2014. PMID: 24553190 Free PMC article. Clinical Trial.

9

Immune response and reactogenicity of an unadjuvanted intradermally delivered human papillomavirus vaccine using a first generation Nanopatch™ in rhesus macaques: An exploratory, pre-clinical feasibility assessment.

Meyer BK, Kendall MAF, Williams DM, Bett AJ, Dubey S, Gentzel RC, Casimiro D, Forster A, Corbett H, Crichton M, Baker SB, Evans RK, Bhambhani A. Meyer BK, et al. Vaccine X. 2019 Jun 20;2:100030. doi: 10.1016/j.jvacx.2019.100030. eCollection 2019 Aug 9. Vaccine X. 2019. PMID: 31384745 Free PMC article.

10

Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in girls aged 9-14 years: Results to month 12 from a randomized trial.

Leung TF, Liu AP, Lim FS, Thollot F, Oh HM, Lee BW, Rombo L, Tan NC, Rouzier R, Friel D, De Muynck B, De Simoni S, Suryakiran P, Hezareh M, Folschweiller N, Thomas F, Struyf F. Leung TF, et al. Hum Vaccin Immunother. 2015;11(7):1689-702. doi: 10.1080/21645515.2015.1050570. Hum Vaccin Immunother. 2015. PMID: 26062002 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year